AU2005238281A1 - A protein involved in cancer - Google Patents
A protein involved in cancer Download PDFInfo
- Publication number
- AU2005238281A1 AU2005238281A1 AU2005238281A AU2005238281A AU2005238281A1 AU 2005238281 A1 AU2005238281 A1 AU 2005238281A1 AU 2005238281 A AU2005238281 A AU 2005238281A AU 2005238281 A AU2005238281 A AU 2005238281A AU 2005238281 A1 AU2005238281 A1 AU 2005238281A1
- Authority
- AU
- Australia
- Prior art keywords
- polypeptide
- flj20584
- cancer
- agent
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0410021.0 | 2004-05-05 | ||
| GBGB0410021.0A GB0410021D0 (en) | 2004-05-05 | 2004-05-05 | A protein involved in cancer |
| PCT/GB2005/001669 WO2005105835A1 (en) | 2004-05-05 | 2005-05-04 | A protein involved in cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2005238281A1 true AU2005238281A1 (en) | 2005-11-10 |
Family
ID=32482711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005238281A Abandoned AU2005238281A1 (en) | 2004-05-05 | 2005-05-04 | A protein involved in cancer |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070269431A1 (https=) |
| EP (1) | EP1747234A1 (https=) |
| JP (1) | JP2008509082A (https=) |
| AU (1) | AU2005238281A1 (https=) |
| CA (1) | CA2562181A1 (https=) |
| GB (1) | GB0410021D0 (https=) |
| WO (1) | WO2005105835A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300418B2 (en) * | 2020-08-06 | 2024-11-01 | Univ Tsinghua | Chemical synthesis of large and mirror-image proteins and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000020029A1 (en) * | 1998-10-05 | 2000-04-13 | Genzyme Corporation | Genes differentially expressed in cancer cells to design cancer vaccines |
| US20070224201A1 (en) * | 2002-10-02 | 2007-09-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| WO2005037865A2 (en) * | 2003-10-16 | 2005-04-28 | Zymogenetics, Inc. | Ztnfr14, A TUMOR NECROSIS FACTOR RECEPTOR |
-
2004
- 2004-05-05 GB GBGB0410021.0A patent/GB0410021D0/en not_active Ceased
-
2005
- 2005-05-04 US US11/587,466 patent/US20070269431A1/en not_active Abandoned
- 2005-05-04 WO PCT/GB2005/001669 patent/WO2005105835A1/en not_active Ceased
- 2005-05-04 AU AU2005238281A patent/AU2005238281A1/en not_active Abandoned
- 2005-05-04 JP JP2007512312A patent/JP2008509082A/ja not_active Abandoned
- 2005-05-04 EP EP05740429A patent/EP1747234A1/en not_active Withdrawn
- 2005-05-04 CA CA002562181A patent/CA2562181A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008509082A (ja) | 2008-03-27 |
| GB0410021D0 (en) | 2004-06-09 |
| CA2562181A1 (en) | 2005-11-10 |
| US20070269431A1 (en) | 2007-11-22 |
| WO2005105835A1 (en) | 2005-11-10 |
| EP1747234A1 (en) | 2007-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9120860B2 (en) | Protein involved in ovarian cancer | |
| JP4446036B2 (ja) | 上皮誘導性癌の治療のための薬剤組成物 | |
| AU2003249072B2 (en) | PTK7 protein involvement in carcinoma | |
| US20070142276A1 (en) | Protein involved in carcinoma | |
| JP2010101901A (ja) | 癌に関与するタンパク質 | |
| US20070269431A1 (en) | Protein Involved In Cancer | |
| US20070141061A1 (en) | Protein involved in carcinoma | |
| US20090214540A1 (en) | Protein involved in cancer | |
| WO2005105143A2 (en) | Vaccines and antibodies against ltk for therapy of cancers. | |
| WO2006000753A2 (en) | Use of flj40787, a protein involved in colon, colorectal, ovarian, lung and/or liver cancer | |
| GB2455634A (en) | Treatment of cancer | |
| WO2006003427A1 (en) | A protein involved in carcinoma | |
| JP2010117358A (ja) | 癌に関与するタンパク質 | |
| WO2005049066A2 (en) | Use of dudulin2 for the treatment or prophylaxis of lung cancer | |
| WO2005019257A1 (en) | A protein involved in pancreatic cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: UCB PHARMA S.A. Free format text: FORMER APPLICANT(S): CELLTECH R&D LIMITED |
|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |